Using The Predictive Alert
You might not want it ON when you are first starting to use a CGM system, but then after that, it is really beneficial. Predictive alert may help you prevent a hyper or hypoglycaemic event.
Setting Alerts Tailored To Your Needs
Even with the best management plan, diabetes can still be unpredictable at times. In addition to the Glucose Level Alerts, your Eversense E3 CGM System has two other alert settings which when turned ON, may help you manage sudden or unexpected changes in glucose levels: Predictive Alerts and Rate of Change Alerts.
The Eversense E3 CGM System is providing On-Body Vibratory Alerts through the smart transmitter and Audio and Visual Alerts on your mobile device for each of those two types of alerts.
Be alerted 10 or 20 or 30 minutes before your sensor glucose level, if it continues at its current rate, will cross the Low or High Glucose Alert Threshold.
Be alerted when your sensor glucose level is changing (rising or falling) faster than the Rate of Change you set in the alert.
It takes practice to determine which of those alerts is most helpful for you. Turn ON and use only those that best support your diabetes management plan and fit your lifestyle. If in doubt, talk to your health care provider to help you choose and set the right alerts for you.
You might not want it ON when you are first starting to use a CGM system, but then after that, it is really beneficial. Predictive alert may help you prevent a hyper or hypoglycaemic event.
The most common use of this type of alert is for a rapid rise in your glucose level to likely indicate that you might have forgotten to bolus with your meal or didn’t bolus enough. Similarly, a rapid fall might indicate that your glucose level is dropping fast from exercise.
If your symptoms are different than the sensor glucose values or what the alert indicates, confirm your glucose value with a fingerstick, using a Blood Glucose meter, before making a treatment decision.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.